Maze Therapeutics Share Price Today: Live Updates & Key Insights
Maze Therapeutics share price today is $47.99, up -2.83%. The stock opened at $48.52 against the previous close of $49.43, with an intraday high of $50.64 and low of $47.92.
Maze Therapeutics Share Price Chart
Maze Therapeutics
Maze Therapeutics Share Price Performance
Maze Therapeutics Institutional Holdings
Maze Therapeutics Market Status
Maze Therapeutics Fundamentals
Market Cap 2311.18 M
PB Ratio 6.086
PE Ratio 0.0
Enterprise Value 1949.50 M
Total Assets 240.54 M
Volume 1329481
Maze Therapeutics Company Financials
About Maze Therapeutics & investment objective
Company Information Maze Therapeutics, Inc., a clinical stage biopharmaceutical company, develops small molecule precision medicines for the treatment of renal, cardiovascular, related metabolic diseases, and obesity in the United States. Its lead programs include MZE829, an oral small molecule inhibitor of apolipoprotein L1, or APOL1, which is in phase II clinical trial for the treatment of patients with APOL1 kidney disease; and MZE782, an oral small molecule inhibitor of the solute transporter SLC6A19, which is in phase I clinical trial for the treatment of chronic kidney disease. The company also offers MZE001, a clinical program for the treatment of Pompe disease. Maze Therapeutics, Inc. was formerly known as Modulus Therapeutics, Inc. and changed its name to Maze Therapeutics, Inc. in September 2018. The company was incorporated in 2017 and is based in South San Francisco, California.
Organisation Biotechnology
Employees 125
Industry Biotechnology
CEO Dr. Jason V. Coloma M.B.A., M.P.H., Ph.D.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
Maze Therapeutics FAQs
What is the share price of Maze Therapeutics today?
The current share price of Maze Therapeutics is $47.99.
Can I buy Maze Therapeutics shares in India?
Yes, Indian investors can buy Maze Therapeutics shares by opening an international trading and demat account with Motilal Oswal.
How to buy Maze Therapeutics shares in India?
You can easily invest in Maze Therapeutics shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Maze Therapeutics shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Maze Therapeutics.
Can I buy fractional shares of Maze Therapeutics?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of Maze Therapeutics?
Maze Therapeutics has a market cap of $2311.18 M.
In which sector does Maze Therapeutics belong?
Maze Therapeutics operates in the Biotechnology sector.
What documents are required to invest in Maze Therapeutics stocks?
To invest, you typically need:
What is the PE and PB ratio of Maze Therapeutics?
The PE ratio of Maze Therapeutics is N/A and the PB ratio is 6.09.